In vitro axotomy models regulated by ROCK inhibitor for studying neuroregeneration and growth cone morphology
Biomedical Journal · 2025
DOI: 10.1016/j.bj.2025.100908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Journal, 2025. Verfasst von Fang Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Brain Aging and Neurodegenerative Diseases, Institute of Clinical Applied Anatomy, The School of Basic Medical Sciences, Fuj…. Hauptthemen laut MEDLINE: Axotomy, rho-Associated Kinases, Nerve Regeneration, Ganglia, Spinal. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fujian Provincial Health Technology Project, Natural Science Foundation of Fujian Province, Fujian Provincial Department of Science and Technology.
Abstract (Originalsprache)
Current complex models of human nerve injury hinder the identification of cellular responses and the screening of therapies. As a solution, simpler in vitro axotomy models utilizing embryonic rat dorsal root ganglion (DRG) and spinal motor neuron aggregates (SMNAs) have been introduced. To ensure model consistency, DRG or SMNA was placed in a cross-shaped channel for axotomy, performed microscopically with a razor. Afterward, the expression of four regeneration-associated genes (RAGs) and regulatory genes was assessed, along with quantifying axon outgrowth and growth cone changes in response to ROCK inhibitor Y27632. Additionally, a mouse perforator flap model was created to evaluate Y27632's effect on DRG axon reinnervation. It turned out that complete and consistent severance of the axons from the DRGs and SMNAs could be easily achieved, with significantly increased expressions of the four RAGs, Rho A and ROCK2. Y27632 could significantly augment axon regeneration in DRGs with axotomy in vitro and in the flap model but showed no impact on DRG axon outgrowth without axotomy. In comparison, Y27632 could slightly increase axon outgrowth from SMNAs without axotomy but drastically boost the axon regeneration from SMNAs with axotomy. The growth cones of DRGs and SMNAs drastically shrunk after axotomy, which could be significantly expanded by Y27632. In contrast, no impact on the growth cones of DRG and SMNAs without axotomy by Y27632 could be observed. The novel in vitro axotomy models regulated by ROCK inhibitors can be used to optimize studies on peripheral nerve injury-related drug screening by observing neuroregeneration and growth cone changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Brain Aging and Neurodegenerative Diseases, Institute of Clinical Applied Anatomy, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Department of Pharmacology, Fuj…
- Department of Spinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Orthopedics, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujia…
Förderung
- Fujian Provincial Health Technology Project
- Natural Science Foundation of Fujian Province
- Fujian Provincial Department of Science and Technology
Zitieren
APA
Fang, F., Xu, D., Dou, S., Zhan, S., Fan, Y., Zhuang, Y., Xu, W., & Xu, Z. (2025). In vitro axotomy models regulated by ROCK inhibitor for studying neuroregeneration and growth cone morphology. Biomedical Journal. https://doi.org/10.1016/j.bj.2025.100908
Vancouver
Fang F, Xu D, Dou S, Zhan S, Fan Y, Zhuang Y, et al. In vitro axotomy models regulated by ROCK inhibitor for studying neuroregeneration and growth cone morphology. Biomedical Journal. 2025. doi:10.1016/j.bj.2025.100908
BibTeX
@article{Fang2025,
author = {Fang, Fang and Xu, Dan and Dou, Shuang and Zhan, Shaoqin and Fan, Yingjuan and Zhuang, Yuehong and Xu, Weihong and Xu, Zixing},
title = {In vitro axotomy models regulated by ROCK inhibitor for studying neuroregeneration and growth cone morphology},
journal = {Biomedical Journal},
year = {2025},
doi = {10.1016/j.bj.2025.100908}
}
EUVIMED